ATE468852T1 - Lofexidine zur intraspinalen anwendung - Google Patents

Lofexidine zur intraspinalen anwendung

Info

Publication number
ATE468852T1
ATE468852T1 AT06254677T AT06254677T ATE468852T1 AT E468852 T1 ATE468852 T1 AT E468852T1 AT 06254677 T AT06254677 T AT 06254677T AT 06254677 T AT06254677 T AT 06254677T AT E468852 T1 ATE468852 T1 AT E468852T1
Authority
AT
Austria
Prior art keywords
lofexidine
intraspinal
patient
intraspinally
analgesia
Prior art date
Application number
AT06254677T
Other languages
English (en)
Inventor
Antonio Romero
Original Assignee
Texcontor Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texcontor Ets filed Critical Texcontor Ets
Application granted granted Critical
Publication of ATE468852T1 publication Critical patent/ATE468852T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
AT06254677T 2005-09-08 2006-09-07 Lofexidine zur intraspinalen anwendung ATE468852T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05255512 2005-09-08

Publications (1)

Publication Number Publication Date
ATE468852T1 true ATE468852T1 (de) 2010-06-15

Family

ID=37856139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06254677T ATE468852T1 (de) 2005-09-08 2006-09-07 Lofexidine zur intraspinalen anwendung

Country Status (3)

Country Link
US (1) US20070060632A1 (de)
AT (1) ATE468852T1 (de)
DE (1) DE602006014480D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010075275A1 (en) * 2008-12-23 2010-07-01 Usworldmeds Llc Selective release of non-racemic mixtures of two enantiomers from tablets and capsules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966757A (en) * 1967-02-23 1976-06-29 A. Nattermann & Cie Gmbh Imidazoline derivatives and processes for the production thereof
US4312879A (en) * 1980-08-14 1982-01-26 Richardson-Merrell Inc. Clonidine and lofexidine as antidiarrheal agents
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
US4382946A (en) * 1981-12-14 1983-05-10 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
US4800209A (en) * 1981-12-14 1989-01-24 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
US4670459A (en) * 1984-10-03 1987-06-02 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
US5863934A (en) * 1995-09-21 1999-01-26 Amy F. T. Arnsten Use of lofexidine in the treatment of behavioral disorders
US20020068754A1 (en) * 1998-02-25 2002-06-06 Olney John W. Combination of adrenergic agonist and aryl-cyclo-alkanolamine for relieving chronic pain without adverse side effects
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030068365A1 (en) * 2001-10-05 2003-04-10 Pichit Suvanprakorn Compositions and methods for administration of active agents using liposome beads
US20050129753A1 (en) * 2003-11-14 2005-06-16 Gabizon Alberto A. Method for drug loading in liposomes
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations

Also Published As

Publication number Publication date
DE602006014480D1 (de) 2010-07-08
US20070060632A1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
EA200970935A1 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
EA200970932A1 (ru) Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа
TW200602048A (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of β -secretase
MA33076B1 (fr) Utilisation d'un inhibiteur de la gamma-secretase pour le traitement du cancer
EA200900177A1 (ru) Замещенные ациланилиды и способы их применения
EA201000914A1 (ru) Новые терапевтические подходы в лечении смт и связанных с ней расстройств
MX2010004494A (es) Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
EP2046315A4 (de) Therapeutische mittel zur behandlung maligner lymphome
ATE532518T1 (de) Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
BRPI0908635B8 (pt) composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
TW200733976A (en) Method for the treatment of cognitive dysfunction
TNSN08506A1 (en) Substituted carboxamides
EA200970816A1 (ru) Новая лекарственная форма
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
DK1732551T3 (da) Perhexilin til behandling af kronisk hjertesvigt
ATE534392T1 (de) Verwendung eines neuen therapeutikums zur behandlung von leukämie
ATE468852T1 (de) Lofexidine zur intraspinalen anwendung
PL379512A1 (pl) Nowe metody i ich zastosowanie
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties